LIPIDS & CARBOHYDRATES
CordenPharma’s scientists have mastered the chemical total synthesis of complex phospholipid derivatives from multi-gram to multi-kilogram scale and are renowned for their contract lipid and phospholipid manufacturing expertise. Our large-scale proprietary cGMP manufacturing processes start with (S)-1,2-isopropylideneglycerol ((S)-IPG) and extend over a cascade of optimised and fully-scalable conversions leading to a wide range of phospholipids such as, but not limited to:
CordenPharma also pioneered the chemistry and large-scale manufacture of MPEG-conjugated phospholipids which can be accessed through the same synthesis cascade, rendering them superior quality products in sensitive liposome formulation processes.
In addition, standard cationic phospholipids such as DODMA and DOTAP can be made available in cGMP and R&D grade qualities.
Please refer to CordenPharma’s Phospholipid Brochure for more details.
A wide selection of Readily Available Phospholipids suitable for Research & Discovery is available for purchase in convenient 1g and 10 g pack sizes (please refer to our Lipid Price List for more details).
To Place An Order for Readily Available Catalog Lipids Please Contact:
CordenPharma also offers cGMP contract manufacturing of proprietary lipids, phospholipids, monoglycerols, diacylglycerols, sphingosines, ceramides and engineered cationic lipids to meet our customers’ tailored demand of custom lipid excipients.
Furthermore, CordenPharma is in a unique position to draw upon this combination of chemistry capabilities to synthesize novel liposome conjugate components conjugated with functional peptides or carbohydrates for targeted drug delivery.
CordenPharma is uniquely positioned to provide development and manufacturing services along the value chain ranging from clinical activities through process development, scale-up and GMP manufacturing of Complex Carbohydrates for a wide range of applications, including:
- >> Glycoconjugate Vaccine Antigens
- >> Immunomodulatory Therapeutics
- >> Tissue Targeting / Drug Delivery Motifs
- >> Carbohydrate-based APIs
CordenPharma provides large-scale cGMP manufacturing at CordenPharma’s facilities in the US and Europe. CordenPharma additionally provides a full range of innovative carbohydrate synthesis and nucleotide derivatives from early-phase through to commercial cGMP manufacturing:
- >> Manufacturing from tens / hundreds of g to multi-kg Production of
- >> Di and Trinucleotide
- >> Cyclic Dinucleotide
- >> Complex Carbohydrates
- >> Glycolipid
- >> GalNac
- >> Phosphatidylinositol
- >> Glycopeptide
- >> Multi-Step Process Engineering Expertise
- >> Modified and / or Regular Phosphoramidites
- >> Proven cGMP Production Capabilities for
- >> Clinical Trial Material
- >> Commercial API Material
CordenPharma’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs), Finished Dosage and Packaging in our network of facilities allows clients full access to integrated services resulting in a simplified supply chain, reduced risk and cost associated with technology transfers, and ultimately faster production and delivery timelines.